Article
Влияние сделок слияния и поглощения на цены акций фармацевтических компаний
The article is dedicated to influence of mergers and acquisitions on stock prices of pharmaceutical companies. Due to active development of pharmaceutical sector and crucial changes in the industry after global strategic deals, there is an uprising interest to the topic. The outcome of the survey helps to investigate previously unstudied features of such strategic contracts for stocks price setting in pharmaceutical sector.
The paper gives common characteristics of the indistry, mergers and acquisitions (which took place on the US market). Event studies method is used to research mergers and acquisitions, resulting in abnormal returns and trading volumes. Obtained results make it possible to formulate conclusions about investor reaction on strategic deals of pharmaceutical companies.
The main aim of the article is to feature historical and modern features of mergers and acquisitions (M&As) deals. For this will be considered: transaction history, the reasons for their appearance, fallacies and self-deceptions during the M&As. Moreover, M&As transactions will be characterized that take place between Russian insurance companies. For example, one of the deals will be characterized on the issue of comparative estimate of the economic productivity (the fit) of its execution.
See the world’s #1 investor like never before―and learn how you can replicate his success
Many books have been written about Warren Buffett’s value-investing strategy, and volumes more have been written about becoming a top-tier value investor. Even so, no one can touch the success Warren Buffett has achieved. Why? In this revealing examination of Buffett’s success, practitioner, professor, and bestselling author Еlena Chirkova proposes the key to replicating his achievements is found in his acquisition practices as well as his investment strategy.
In The Warren Buffett Philosophy of Investment, she looks at the man in full to piece together the framework leading to his unmatched wealth-generating prowess. The cornerstone of her study goes beyond investment theory to show Buffett’s core wealth drivers are his philosophies behind Berkshire Hathaway. From his decision to create a joint stock company (instead of a mutual fund) to his hands-off policy with acquired companies to making himself a brand-name of mergers and acquisitions―she illustrates an intimate portrayal of Buffett operating behind the scenes by piecing together his career with scholarly diligence and scrutiny. Even well-read Buffett followers gain fresh insight into the man by discovering:
Where his divergence from the principals of Ben Graham and Philip Fisher make him a superior investor Why his unorthodox perspective on the financial markets keep him ahead of the curve How his vision of risk, interpretation of volatility, and scepticism about investing in technology companies are interconnected What he sees as the critical problems of corporate financeAdditionally, readers are treated to extraordinary coverage of how Buffett strategically set up Berkshire Hathaway to suit his personal long-term investment strategy and provide almost cost-free leverage. See how Buffett’s singular acquisition tactics and portfolio investments earned Berkshire Hathaway the distinction as “the right home for the right people,” which gives him access to deals unobtainable by other companies and investors.
You’re only investing with half a strategy until you take your value investing to the next level with The Warren Buffett Philosophy of Investment.
This paper is devoted to the analysis of mergers and acquisitions in Russia. Using the statistical and econometric methods the estimation of macroeconomic and industry factors influence on the intensity of mergers and acquisitions processes by sectors of Russian industry is carried out. As a result the relationship between the activity of the redistribution process of the corporate control rights and some industry characteristics such as an involvement into the foreign trade, the relative industry size, the concentration of production is revealed.
The paper considers the prospects of domestic pharmaceutical industry development and determines the requirements for strategic growth for the drug manufacturers. Particularly highlighted are the results of examining the present situation in the domestic pharmaceutical industry as well as the analysis of international experience. The author determines the main growth aims of the domestic pharmaceutical companies and suggests the measures aimed at their reaching.
Smoking is a problem, bringing signifi cant social and economic costs to Russiansociety. However, ratifi cation of the World health organization Framework conventionon tobacco control makes it possible to improve Russian legislation accordingto the international standards. So, I describe some measures that should be taken bythe Russian authorities in the nearest future, and I examine their effi ciency. By studyingthe international evidence I analyze the impact of the smoke-free areas, advertisementand sponsorship bans, tax increases, etc. on the prevalence of smoking, cigaretteconsumption and some other indicators. I also investigate the obstacles confrontingthe Russian authorities when they introduce new policy measures and the public attitudetowards these measures. I conclude that there is a number of easy-to-implementanti-smoking activities that need no fi nancial resources but only a political will.
One of the most important indicators of company's success is the increase of its value. The article investigates traditional methods of company's value assessment and the evidence that the application of these methods is incorrect in the new stage of economy. So it is necessary to create a new method of valuation based on the new main sources of company's success that is its intellectual capital.